Goodwin to manufacture ADC for Aspyrian
Aspyrian Therapeutics has selected CDMO Goodwin Biotechnology to complete process development, scale-up, and cGMP manufacturing of their novel antibody drug conjugate (ADC).
Archives for June 9, 2015
Pharma: Ensuring supply is priority as Greek drug debt passes €1.1bn
Drug companies will continue to supply Greece for the time being, but mounting debts make it hard to predict what will happen in the longer term according to industry group EFPIA.
Recipharm’s revenue model praised by Swedish industry group
Recipharm has been awarded commended for its revenue model and “achievements and success beyond the norm” by industry group, SwedenBio.
Exporting to Brazil? ANVISA is tough and hands-on, says Kemwell
Site audits by Brazilian pharma regulator ANVISA are “exactly the opposite” to the US FDA’s, says CMO Kemwell as it prepares to export to Brazil for Johnson & Johnson.
update
Data from all UK-funded vaccine trials to be published says PM
Results from all UK-funded vaccine trials will be made public according to Prime Minister David Cameron, who suggested failure to share data exacerbated the Ebola outbreak.
CRO market poised for 6% annual growth, Icon CFO says
As biotech cash continues to flood the coffers of CROs (contract research organizations), large pharma R&D is still relatively flat, which means CROs will see about 6% growth annually, Brendan Brennan, CFO of Icon, told investors last week at the...
Nucleation knowhow can aid API makers say crystal experts due to meet in France
Crystallisation experts from across Europe will meet in France this month to share ideas and research that will shape how APIs are made in the future.